CABA Cabaletta Bio, Inc.
1.970USD-2.48%Mkt Cap: 334.00M $P/E: —1d ago
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. The company's lead product candidate is resecabt…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap334.00M USD
Enterprise Value143.09M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-167.86M USD
Revenue/Share—
Last Price1.970 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees154
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.70
PEG—
EV/EBITDA-0.78
EV/Revenue—
P/S—
P/B1.61
EPS (TTM)-1.47
EPS (Forward)-1.19
52W Range
1.8306% of range4.230
52W High4.230 USD
52W Low1.830 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-149.80%
ROA-101.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-131.08M USD
CapEx (TTM)1.23M USD
FCF Margin—
FCF Yield-29.44%
Net Debt-199.39M USD
Net Debt/EBITDA1.08
Balance Sheet
Debt/Equity0.24
Current Ratio5.79
Quick Ratio5.64
Book Value/Sh1.26 USD
Cash/Share1.33 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)13.25 USD
Upside (mean)+572.6%
Target Range3.000 USD – 30.00 USD
3.000+572.6% to mean30.00
# Analysts8
Ownership
Shares Out.169.55M
Float141.48M
Insiders0.97%
Institutions94.42%
Short Interest
Short Ratio5.8d
Short % Float21.67%
Short % Out.19.66%
Shares Short33.33M
Short (prev mo.)42.80M
Technical
SMA 502.747 (-28.3%)
SMA 2002.911 (-32.3%)
Beta3.48
S&P 52W Chg16.45%
Avg Vol (30d)5.95M
Avg Vol (10d)6.00M
Technical Indicators
RSI (14)32.7
MACD-0.2562
MACD Signal-0.2333
MACD Hist.-0.0229
BB Upper3.162 USD
BB Middle2.349 USD
BB Lower1.535 USD
BB Width69.27%
ATR (14)0.1834 USD
Vol Ratio (20d)0.35x